Euro vs US Dollar

Registrieren Sie sich für Echtzeit-Benachrichtigungen, benutzerdefinierte Portfolios und Marktbewegungen.

Registrieren

PRLD Prelude Therapeutics Inc

4,07

0,48 (13,37%)

Nach Börsenschluss

Zuletzt aktualisiert: 22:00:06

Verzögert um 15 Minuten

Form 10-K - Annual report [Section 13 and 15(d), not S-K Item 405]

Article too big to display. Click here to view on the SEC website

Prelude Therapeutics (NASDAQ:PRLD)
Historical Stock Chart
Von Apr 2024 bis Mai 2024

Click Here for more Prelude Therapeutics Charts.

Prelude Therapeutics (NASDAQ:PRLD)
Historical Stock Chart
Von Mai 2023 bis Mai 2024

Click Here for more Prelude Therapeutics Charts.

News Prelude Therapeutics Inc

Prelude Therapeutics to Participate in Citizens JMP Life Sciences Conference
Donnerstag 9 Mai 2024 (10 Stunden vor) • GlobeNewswire Inc.

Form EFFECT - Notice of Effectiveness
Donnerstag 9 Mai 2024 (17 Stunden vor) • Edgar (US Regulatory)

Form 10-Q - Quarterly report [Sections 13 or 15(d)]
Dienstag 7 Mai 2024 (2 Tage vor) • Edgar (US Regulatory)

Form 8-K - Current report
Dienstag 7 Mai 2024 (2 Tage vor) • Edgar (US Regulatory)

Prelude Therapeutics Reports First Quarter 2024 Financial Results and Provides Corporate Update
Dienstag 7 Mai 2024 (2 Tage vor) • GlobeNewswire Inc.

Form S-3/A - Registration statement under Securities Act of 1933: [Amend]
Montag 6 Mai 2024 (3 Tage vor) • Edgar (US Regulatory)

Prelude Highlights Continued Strength of Discovery Engine at 2024 AACR Annual Meeting
Dienstag 9 April 2024 (1 Monat vor) • GlobeNewswire Inc.

Prelude Announces Acceptance of Multiple Preclinical Abstracts at the 2024 AACR Annual Meeting
Dienstag 5 März 2024 (2 Monate vor) • GlobeNewswire Inc.

Form 4 - Statement of changes in beneficial ownership of securities
Dienstag 5 März 2024 (2 Monate vor) • Edgar (US Regulatory)

Form 4 - Statement of changes in beneficial ownership of securities
Dienstag 5 März 2024 (2 Monate vor) • Edgar (US Regulatory)

Form 4 - Statement of changes in beneficial ownership of securities
Dienstag 5 März 2024 (2 Monate vor) • Edgar (US Regulatory)

Form 4 - Statement of changes in beneficial ownership of securities
Dienstag 5 März 2024 (2 Monate vor) • Edgar (US Regulatory)

Weitere Prelude Therapeutics Inc News-Artikel

Invesco QQQ Trust Series 1

Deutsche Telekom (QX)

Financial Select Sector

Delayed Upgrade Clock

Support: +44 (0) 203 8794 460 | support@advfn.de

Durch das Benutzen des ADVFN Angebotes akzeptieren Sie folgende Allgemeine Geschäftsbedingungen